Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02192775
Title UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Arkansas
Indications

multiple myeloma

Therapies

MV-NIS

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.